DESARROLLOS FUTUROS EN LA INVESTIGACIÓN DE LA INTERFAZ CEREBRO-MÁQUINA

Autores/as

  • Alejandro Costa Unidad Independiente de Estudios de Innovación Biofarma
  • Carlos Mendoza Unidad Independiente de Estudios de Innovación Biofarma

DOI:

https://doi.org/10.59087/biofarma.v4i1.40

Palabras clave:

interfaz cerebro-máquina, neurotecnología, etica

Resumen

Este artículo explora los desarrollos futuros en la investigación de las interfaces cerebro-máquina (IMC), destacando sus avances, desafíos y perspectivas. La interfaz cerebro-máquina representa una intersección dinámica entre la neurociencia, la ingeniería y la medicina, y progresa rápidamente para restaurar la función motora en personas con discapacidades graves. Las investigaciones futuras deberían abordar cuestiones éticas, la precisión de las señales neuronales y el desarrollo de dispositivos más asequibles y no invasivos. Si bien los MCI presentan un potencial significativo, aún quedan muchos obstáculos técnicos y sociales por superar.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Almeida, G. M., Almeida, A. B., & Sato, E. (2021). The Role of Mobile Health Technologies in Medication Adherence: A Systematic Review. Journal of Pharmaceutical Health Services Research, 12(1), 233-240.

Bhatia, S., Chatterjee, P., & Kaur, J. (2019). Telepharmacy: Bridging the Gap in Pharmaceutical Care. Canadian Journal of Pharmacy Technology, 12(3), 87-92.

Blenkinsopp, A., Bond, C., & Hutchinson, K. (2018). The Expanded Role of the Pharmacist in Health Care Teams: A Systematic Review. Health Services Research, 53(4), 2999-3020.

Brasil, L., Silva, J., & Ferreira, A. (2022). Telemedicina e Farmácia Clínica no Brasil: Desafios e Oportunidades. Revista Brasileira de Farmácia, 15(2), 67-73.

Chen, J., Zhang, A., & Wang, J. (2020). Artificial Intelligence in Health Care: Anticipating Challenges to Ethics, Data Protection, and the Law. Journal of Medical Ethics, 46(11), 736-743.

Ghassemi, M. M., Naumann, T., & Laird, T. (2022). Ethical Considerations in the Use of AI in Healthcare: The Need for Regulatory Frameworks. Health Affairs, 41(1), 42-49.

Hogue, M. D., Leclercq, H., & Baby, J. M. (2020). Pharmacists’ Views on Telehealth: A Canadian Perspective. Canadian Pharmacists Journal, 153(4), 205-211.

Johnson, R., Smith, L., & Taylor, M. (2022). The Impact of Digital Tools on Patient Adherence in Australia. Australian Journal of Pharmacy, 73(2), 45-50.

Jiang, F., Jiang, Y., Zhi, H., & Li, H. (2017). Artificial Intelligence in Health Care: Anticipating Challenges to Ethics, Data Protection, and the Law. Journal of Medical Systems, 41(4), 62.

Kheir, N. A., Awaisu, A., & Shakir, M. (2019). The Impact of Clinical Pharmacy Services on Patient Outcomes in Community Settings: A Systematic Review. International Journal of Clinical Pharmacy, 41(2), 378-399.

Klein, K., Grimes, D., & Knox, K. (2021). Patient Perspectives on Data Privacy in Digital Health: A Survey Study. Journal of Medical Internet Research, 23(4), e23672.

Lu, Y., Weng, W. H., & Chen, Y. (2020). Ethical Considerations in Big Data and Health Data Research: A Review. Journal of Health Ethics, 16(1), 1-10.

McGowan, J. R., O’Brien, B. S., & O’Rourke, J. (2021). The Clinical Pharmacy Services in Canada: A Review of Current Practices and Future Directions. Canadian Journal of Hospital Pharmacy, 74(6), 38-45.

Müller, S., Fischer, K., & Weber, D. (2021). The Role of Pharmacists in Chronic Disease Management in Europe: A Systematic Review. European Journal of Public Health, 31(2), 345-351.

Oliveira, T. R., Santos, M. M., & Lima, C. M. (2023). Impacto da Tecnologia na Adesão ao Tratamento no Brasil. Revista Brasileira de Epidemiologia, 26(1), e23010.

Pereira, L. A., & Almeida, R. S. (2023). Responsible Use of AI in Healthcare: Promoting a Dialogue Between Science and Regulatory Bodies. Journal of Public Health Policy, 44(1), 23-35.

Renaud, K., Marshall, T., & Keith, M. (2021). The Effect of Technology Training on Pharmacists’ Confidence: Results from a Multisite Study. Pharmacy Practice, 19(3), 2044.

Sharma, R., Smith, A. J., & Patel, S. (2023). AI-Driven Clinical Trial Design: Improving Efficiency and Quality in Research. Trials, 24(1), 100.

Smith, A. C., Jones, L. M., & Brown, F. (2021). Patient Satisfaction with Telepharmacy Services in the United States: A National Survey. Journal of Telehealth and Telecare, 27(4), 208-215.

Silva, J., Gonçalves, R. & Almeida, S. (2022). Avaliação dos Serviços de Farmácia Clínica no Brasil. Revista de Ciências Farmacêuticas, 29(4), 300-311.

Souza, R. D. S. (2023). Integração da Inteligência Artificial no Processo Farmacêutico: Desafios e Oportunidades. Zenodo. https://doi.org/10.5281/zenodo.13974319

Wong, M. C. S., Wang, K., & Wong, I. C. K. (2020). The Role of Pharmacists in Community Health: A Review of Current Practice in Canada. Canadian Pharmacists Journal, 153(3), 169-174.

Wubineh, A., Slama, S., & Nafcuy, R. (2023). The Need for a Regulatory Framework for AI in Healthcare: Ethical Considerations. Journal of Health Policy and Management, 18(2), 134-142.

Publicado

2024-10-31

Cómo citar

Costa, A., & Mendoza, C. (2024). DESARROLLOS FUTUROS EN LA INVESTIGACIÓN DE LA INTERFAZ CEREBRO-MÁQUINA. Biofarma - Multidisciplinary Scientific Journal of Biology, Pharmacy and Health, 4(1). https://doi.org/10.59087/biofarma.v4i1.40